Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-114412
Filing Date
2015-03-31
Accepted
2015-03-31 17:16:40
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d846215d10k.htm 10-K 830879
2 EX-3.8 d846215dex38.htm EX-3.8 121800
3 EX-4.11 d846215dex411.htm EX-4.11 216521
4 EX-4.12 d846215dex412.htm EX-4.12 89378
5 EX-4.13 d846215dex413.htm EX-4.13 74090
6 EX-10.15 d846215dex1015.htm EX-10.15 112694
7 EX-10.29 d846215dex1029.htm EX-10.29 106115
8 EX-10.30 d846215dex1030.htm EX-10.30 30727
9 EX-23.1 d846215dex231.htm EX-23.1 1800
10 EX-31.1 d846215dex311.htm EX-31.1 8732
11 EX-31.2 d846215dex312.htm EX-31.2 8743
12 EX-32.1 d846215dex321.htm EX-32.1 3718
13 EX-32.2 d846215dex322.htm EX-32.2 3734
14 EX-99.1 d846215dex991.htm EX-99.1 628
15 GRAPHIC g846215g16g05.jpg GRAPHIC 26783
  Complete submission text file 0001193125-15-114412.txt   1647739
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31265 | Film No.: 15740357
SIC: 2834 Pharmaceutical Preparations